Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(TSV:
ZYUS
)
0.6500
UNCHANGED
Streaming Delayed Price
Updated: 9:31 AM EST, Feb 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.6500
Bid (Size)
0.6200 (90)
Ask (Size)
0.6700 (110)
Prev. Close
0.6500
Today's Range
0.6500 - 0.6500
52wk Range
0.4800 - 0.8500
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ZYUS Life Sciences Finalizing Site Initiation for Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug
May 22, 2025
From
ZYUS Life Sciences Corporation
Via
Business Wire
INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9
May 07, 2024
From
ZYUS Life Sciences Corporation
Via
Business Wire
Performance
YTD
-4.4%
-4.4%
1 Month
-4.4%
-4.4%
3 Month
-5.8%
-5.8%
6 Month
-9.7%
-9.7%
1 Year
-23.5%
-23.5%
More News
Read More
ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management
April 23, 2024
From
ZYUS Life Sciences Corporation
Via
Business Wire
Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes
↗
February 20, 2024
Via
Benzinga
Topics
Cannabis
ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke
February 01, 2024
From
ZYUS Life Sciences Corporation
Via
Business Wire
ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research
January 09, 2024
From
ZYUS Life Sciences Corporation
Via
Business Wire
ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management
December 05, 2023
From
ZYUS Life Sciences Corporation
Via
Business Wire
ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels
November 21, 2023
From
ZYUS Life Sciences Corporation
Via
Business Wire
ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets
October 24, 2023
From
ZYUS Life Sciences Corporation
Via
Business Wire
Frequently Asked Questions
Is ZYUS publicly traded?
Yes, ZYUS is publicly traded.
What exchange does ZYUS trade on?
ZYUS trades on the Toronto Venture Stock Exchange
What is the ticker symbol for ZYUS?
The ticker symbol for ZYUS is ZYUS on the Toronto Venture Stock Exchange
What is the current price of ZYUS?
The current price of ZYUS is 0.6500
When was ZYUS last traded?
The last trade of ZYUS was at 02/12/26 09:31 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.